Munro Partners Purchases 2,325 Shares of Linde PLC $LIN

Munro Partners grew its position in Linde PLC (NASDAQ:LIN) by 5.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 43,139 shares of the basic materials company’s stock after acquiring an additional 2,325 shares during the quarter. Munro Partners’ holdings in Linde were worth $20,491,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Darwin Wealth Management LLC purchased a new stake in Linde in the second quarter worth $25,000. eCIO Inc. bought a new position in shares of Linde in the first quarter worth about $45,000. Howard Hughes Medical Institute purchased a new position in Linde in the 2nd quarter worth about $48,000. Nova Wealth Management Inc. purchased a new position in Linde in the 1st quarter worth about $52,000. Finally, Activest Wealth Management lifted its holdings in Linde by 5,800.0% during the 1st quarter. Activest Wealth Management now owns 118 shares of the basic materials company’s stock valued at $55,000 after buying an additional 116 shares in the last quarter. 82.80% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on LIN shares. UBS Group reaffirmed a “buy” rating on shares of Linde in a research report on Friday, December 12th. Weiss Ratings cut Linde from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday. Seaport Res Ptn raised Linde from a “hold” rating to a “strong-buy” rating in a research report on Monday, November 3rd. Mizuho set a $495.00 target price on Linde in a report on Thursday, December 11th. Finally, Royal Bank Of Canada cut their price target on Linde from $540.00 to $490.00 and set an “outperform” rating on the stock in a research note on Friday, December 12th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, Linde presently has an average rating of “Buy” and an average target price of $501.00.

Linde Stock Performance

Shares of NASDAQ:LIN opened at $425.10 on Wednesday. The firm has a 50 day moving average of $421.11 and a 200 day moving average of $453.39. The company has a quick ratio of 0.69, a current ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $198.50 billion, a price-to-earnings ratio of 28.47, a price-to-earnings-growth ratio of 3.25 and a beta of 0.85. Linde PLC has a 52 week low of $387.78 and a 52 week high of $486.38.

Linde (NASDAQ:LIN) last announced its earnings results on Friday, October 31st. The basic materials company reported $4.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.18 by $0.03. The business had revenue of $8.62 billion for the quarter, compared to analysts’ expectations of $8.62 billion. Linde had a return on equity of 19.38% and a net margin of 21.17%.The business’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter last year, the firm earned $3.94 EPS. Linde has set its FY 2025 guidance at 16.350-16.450 EPS and its Q4 2025 guidance at 4.100-4.200 EPS. On average, sell-side analysts predict that Linde PLC will post 16.54 earnings per share for the current fiscal year.

Linde Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 17th. Shareholders of record on Wednesday, December 3rd were paid a $1.50 dividend. This represents a $6.00 annualized dividend and a yield of 1.4%. The ex-dividend date was Wednesday, December 3rd. Linde’s payout ratio is 40.19%.

About Linde

Linde (NASDAQ: LIN) is a multinational industrial gases and engineering company that supplies gases, related technologies and services to a wide range of industries. The company traces its current form to the 2018 combination of Germany’s Linde AG and U.S.-based Praxair, creating one of the largest global providers of industrial, specialty and medical gases. Linde’s business model centers on production, processing and distribution of gases as well as the design and construction of the plants and equipment needed to produce them.

Core products and services include atmospheric and process gases such as oxygen, nitrogen and argon; hydrogen and helium; carbon dioxide; and a portfolio of higher?value specialty and electronic gases.